Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q419769> ?p ?o }
Showing triples 1 to 62 of
62
with 100 triples per page.
- Q419769 subject Q5920511.
- Q419769 subject Q7335338.
- Q419769 subject Q8413416.
- Q419769 subject Q8824860.
- Q419769 subject Q8965786.
- Q419769 subject Q9052781.
- Q419769 abstract "Bosentan is a dual endothelin receptor antagonist used in the treatment of pulmonary artery hypertension (PAH). It is licensed in the United States, the European Union and other countries by Actelion Pharmaceuticals for the management of PAH under the trade name Tracleer.".
- Q419769 atcPrefix "C02".
- Q419769 atcSuffix "KX01".
- Q419769 bioavailability "50.0".
- Q419769 casNumber "147536-97-8".
- Q419769 chEBI "51450".
- Q419769 drugbank "DB00559".
- Q419769 fdaUniiCode "XUL93R30K2".
- Q419769 iupacName "4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]benzene-1-sulfonamide".
- Q419769 pubchem "104865".
- Q419769 thumbnail Bosentan.svg?width=300.
- Q419769 wikiPageExternalLink index.php?title=Bosentan.
- Q419769 wikiPageExternalLink www.tracleer.com.
- Q419769 wikiPageExternalLink 09%20276%2001%2000%200809_Tra%20PI_4%20Pg_081409pdf.pdf.
- Q419769 wikiPageWikiLink Q111146.
- Q419769 wikiPageWikiLink Q1128595.
- Q419769 wikiPageWikiLink Q1349821.
- Q419769 wikiPageWikiLink Q1359801.
- Q419769 wikiPageWikiLink Q204711.
- Q419769 wikiPageWikiLink Q30.
- Q419769 wikiPageWikiLink Q343217.
- Q419769 wikiPageWikiLink Q390566.
- Q419769 wikiPageWikiLink Q390709.
- Q419769 wikiPageWikiLink Q410789.
- Q419769 wikiPageWikiLink Q456026.
- Q419769 wikiPageWikiLink Q458.
- Q419769 wikiPageWikiLink Q5225810.
- Q419769 wikiPageWikiLink Q5340515.
- Q419769 wikiPageWikiLink Q5445.
- Q419769 wikiPageWikiLink Q5920511.
- Q419769 wikiPageWikiLink Q631521.
- Q419769 wikiPageWikiLink Q7335338.
- Q419769 wikiPageWikiLink Q8413416.
- Q419769 wikiPageWikiLink Q8824860.
- Q419769 wikiPageWikiLink Q8965786.
- Q419769 wikiPageWikiLink Q9052781.
- Q419769 wikiPageWikiLink Q905664.
- Q419769 wikiPageWikiLink Q9368.
- Q419769 atcPrefix "2.0".
- Q419769 atcSuffix "KX01".
- Q419769 bioavailability "50.0".
- Q419769 casNumber "147536".
- Q419769 chebi "51450".
- Q419769 drugbank "DB00559".
- Q419769 iupacName "4".
- Q419769 pubchem "104865".
- Q419769 unii "XUL93R30K2".
- Q419769 type ChemicalSubstance.
- Q419769 type Drug.
- Q419769 type ChemicalObject.
- Q419769 type Thing.
- Q419769 type Q8386.
- Q419769 comment "Bosentan is a dual endothelin receptor antagonist used in the treatment of pulmonary artery hypertension (PAH). It is licensed in the United States, the European Union and other countries by Actelion Pharmaceuticals for the management of PAH under the trade name Tracleer.".
- Q419769 label "Bosentan".
- Q419769 depiction Bosentan.svg.
- Q419769 homepage www.tracleer.com.